{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T03:10:11Z","timestamp":1711422611760},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,5,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>We investigated the effect angiotensin II (Ang II), a corpus cavernosal smooth muscle (CCSM) constrictor peptide, has on tissue taken from rabbits following chronic partial bladder outlet obstruction (PBOO), as this model is characterized by an increase in corpus cavernosal collagen deposition and a marked reduction and impaired relaxation of CCSM cells.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Aim<\/jats:title>\n                  <jats:p>To determine the interaction between Ang II and nitric oxide (NO) and the development of oxidative stress (OS) in a rabbit model of chronic PBOO.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Corpus cavernosal tissue was obtained from 12 sham-operated and 20 PBOO rabbits. Organ bath studies determined Ang II\/NO interaction on CCSM function using losartan (AT1 receptor antagonist), sodium nitroprusside (SNP, NO donor), electrical field stimulation (EFS), and vardenafil (phosphodiesterase type 5 inhibitor). The role of OS in the Ang II response was also determined using diphenylene iodonium chloride (DPI), the nicotinamide adenine dinucleotide phosphate oxidase inhibitor, which inhibits superoxide production and superoxide dismutase (SOD, the enzyme that accelerates the breakdown of superoxide).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Main Outcome Measure<\/jats:title>\n                  <jats:p>Action of Ang II and AT1 receptor antagonist, as well as SOD and DPI on CCSM function.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Ang II caused a dose-dependent contraction of CCSM strips that was enhanced in PBOO rabbits and inhibited by losartan, DPI, and SOD. CCSM relaxation induced by SNP\/EFS was impaired in this model and improved by vardenafil and losartan.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>These findings imply that the increased Ang II contractile response is a pathological consequence of PBOO and that AT1 receptor inhibition may be a therapeutic approach to treat ED associated with PBOO.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1111\/j.1743-6109.2012.02768.x","type":"journal-article","created":{"date-parts":[[2012,5,21]],"date-time":"2012-05-21T15:19:27Z","timestamp":1337613567000},"page":"1251-1258","source":"Crossref","is-referenced-by-count":3,"title":["Angiotensin II Increases Corpus Cavernosal Contractility and Oxidative Stress in Partial Bladder Outlet Obstructed Rabbits: Relevance to Erectile Dysfunction"],"prefix":"10.1093","volume":"10","author":[{"given":"Hani","family":"Ertemi","sequence":"first","affiliation":[{"name":"Departments of General Surgery and Clinical Biochemistry \u00a0 \u00a0 , London , UK"},{"name":"Division of Interventional Science \u00a0 \u00a0 , London , UK"},{"name":"University College London Medical School \u00a0 \u00a0 , London , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David H.W.","family":"Lau","sequence":"additional","affiliation":[{"name":"Departments of General Surgery and Clinical Biochemistry \u00a0 \u00a0 , London , UK"},{"name":"Division of Interventional Science \u00a0 \u00a0 , London , UK"},{"name":"University College London Medical School \u00a0 \u00a0 , London , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitri P.","family":"Mikhailidis","sequence":"additional","affiliation":[{"name":"Departments of General Surgery and Clinical Biochemistry \u00a0 \u00a0 , London , UK"},{"name":"Division of Interventional Science \u00a0 \u00a0 , London , UK"},{"name":"University College London Medical School \u00a0 \u00a0 , London , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faiz H.","family":"Mumtaz","sequence":"additional","affiliation":[{"name":"Department of Urology \u00a0 , Enfield , UK"},{"name":"Chase Farm Hospital \u00a0 , Enfield , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecil S.","family":"Thompson","sequence":"additional","affiliation":[{"name":"Departments of General Surgery and Clinical Biochemistry \u00a0 \u00a0 , London , UK"},{"name":"Division of Interventional Science \u00a0 \u00a0 , London , UK"},{"name":"University College London Medical School \u00a0 \u00a0 , London , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2013,5,1]]},"reference":[{"key":"2024032602340795800_bb0010","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S0022-5347(17)49698-4","article-title":"The development of human benign prostatic hyperplasia with age","volume":"132","author":"Berry","year":"1984","journal-title":"J Urol"},{"key":"2024032602340795800_bb0015","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/nau.1010","article-title":"Interactions between prostate volume, filling cystometric estimated parameters, and data from pressure-flow studies in 565 men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia","volume":"20","author":"Eckhardt","year":"2001","journal-title":"Neurourol Urodyn"},{"issue":"1","key":"2024032602340795800_bb0020","first-page":"3","article-title":"Bladder consequences of prostatic obstruction","volume":"32","author":"Mauroy","year":"1997","journal-title":"Eur Urol"},{"key":"2024032602340795800_bb0025","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1464-410X.2008.08324.x","article-title":"The effect of sildenafil citrate on bladder outlet obstruction: A mouse model","volume":"104","author":"Beamon","year":"2008","journal-title":"BJU Int"},{"key":"2024032602340795800_bb0030","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1016\/S0022-5347(05)65825-9","article-title":"Alterations in cholinergic and purinergic signalling in a model of the obstructed bladder","volume":"166","author":"Calvert","year":"2001","journal-title":"J Urol"},{"key":"2024032602340795800_bb0035","doi-asserted-by":"crossref","first-page":"R2390","DOI":"10.1152\/ajpregu.00508.2007","article-title":"Effect of L-arginine and L-NAME on chronic partial bladder outlet obstruction in rabbit","volume":"293","author":"Lin","year":"2007","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"2024032602340795800_bb0040","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1046\/j.1464-410X.1998.00868.x","article-title":"The evaluation of sexual function in men presenting with symptomatic benign prostatic hyperplasia","volume":"82","author":"Namasivayam","year":"1998","journal-title":"Br J Urol"},{"key":"2024032602340795800_bb0045","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.urology.2008.05.034","article-title":"Association of sexual dysfunction with lower urinary tract symptoms of BPH and BPH medical therapies: Results from the BPH registry","volume":"73","author":"Rosen","year":"2009","journal-title":"Urology"},{"key":"2024032602340795800_bb0050","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1159\/000020252","article-title":"Sexual function in 131 patients with benign prostatic hyperplasia before prostatectomy","volume":"38","author":"Baniel","year":"2000","journal-title":"Eur Urol"},{"issue":"1","key":"2024032602340795800_bb0055","doi-asserted-by":"crossref","first-page":"s63","DOI":"10.1185\/0300799009117042","article-title":"Benign prostatic hyperplasia and erectile dysfunction\u2014Is there a link?","volume":"16","author":"Vale","year":"2000","journal-title":"Curr Med Res Opin"},{"key":"2024032602340795800_bb0060","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1016\/S0022-5347(05)65050-1","article-title":"Enhanced force generation by corpus cavernosum smooth muscle in rabbits with partial bladder outlet obstruction","volume":"167","author":"Chang","year":"2002","journal-title":"J Urol"},{"key":"2024032602340795800_bb0065","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/nau.20607","article-title":"The effect of chronic partial bladder outlet obstruction on corpus cavernosum smooth muscle and rho-kinase in rabbits","volume":"27","author":"Lin","year":"2008","journal-title":"Neurourol Urodyn"},{"key":"2024032602340795800_bb0070","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/s003450050148","article-title":"Down-regulation of endothelin-B receptor sites in cavernosal tissue of a rabbit model of partial bladder outlet obstruction: Potential clinical relevance","volume":"17","author":"Khan","year":"1999","journal-title":"World J Urol"},{"key":"2024032602340795800_bb0075","first-page":"S58","article-title":"Alterations in cavernosal nitric oxide signalling providing evidence linking bladder outflow obstruction to erectile dysfunction","volume":"13","author":"Calvert","year":"2001","journal-title":"Int J Impot Res"},{"key":"2024032602340795800_bb0080","first-page":"S58","article-title":"Impairment of ATP-mediated cavernosal smooth muscle relaxation in a rabbit model of partial bladder outlet obstruction","volume":"13","author":"Calvert","year":"2001","journal-title":"Int J Impot Res"},{"key":"2024032602340795800_bb0085","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1016\/S0022-5347(17)37667-X","article-title":"Phospholipase C activation by endothelin-1 and noradrenaline in isolated penile erectile tissue from rabbit","volume":"147","author":"Holmquist","year":"1992","journal-title":"J Urol"},{"key":"2024032602340795800_bb0090","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1016\/j.juro.2011.02.2645","article-title":"Effect of angiotensin II and its receptor antagonists on human corpus cavernosal contractility and oxidative stress: Modulation of nitric oxide-mediated relaxation","volume":"185","author":"Ertemi","year":"2011","journal-title":"J Urol"},{"key":"2024032602340795800_bb0095","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1016\/S0022-5347(01)64901-2","article-title":"Tissue angiotensin II as a modulator of erectile function. 1. Angiotensin peptide content, secretion and effects in the corpus cavernosum","volume":"157","author":"Kifor","year":"1997","journal-title":"J Urol"},{"key":"2024032602340795800_bb0100","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0090-4295(01)01312-7","article-title":"Plasma levels of angiotensin II during different penile conditions in the cavernous and systemic blood of healthy men and patients with erectile dysfunction","volume":"58","author":"Becker","year":"2001","journal-title":"Urology"},{"key":"2024032602340795800_bb0105","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1161\/01.ATV.0000046231.17365.9D","article-title":"Functional interplay between angiotensin II and nitric oxide","volume":"23","author":"Yan","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2024032602340795800_bb0110","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S0022-5347(01)64577-4","article-title":"Renin angiotensin system in rabbit corpus cavernosum: Functional characterization of angiotensin II receptors","volume":"158","author":"Park","year":"1997","journal-title":"J Urol"},{"key":"2024032602340795800_bb0115","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1097\/01.hjh.0000220406.46246.f2","article-title":"Interaction between nitric oxide and angiotensin II in the endothelium: Role in atherosclerosis and hypertension","volume":"24","author":"Schulman","year":"2006","journal-title":"J Hypertens"},{"key":"2024032602340795800_bb0120","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/00004872-200018020-00008","article-title":"Acute production of vascular superoxide by Ang-II but not by catecholamines","volume":"18","author":"Kawazoe","year":"2000","journal-title":"J Hypertens"},{"key":"2024032602340795800_bb0125","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1097\/01.CCM.0000186759.13325.DC","article-title":"Marked synergism between vasopressin and angiotensin II in a human isolated artery","volume":"33","author":"Hidaka","year":"2005","journal-title":"Crit Care Med"},{"key":"2024032602340795800_bb0130","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1159\/000137649","article-title":"Effects of partial bladder outlet obstruction on contraction and relaxation response of rabbit corpus cavernosum","volume":"81","author":"Demir","year":"2008","journal-title":"Urol Int"},{"key":"2024032602340795800_bb0135","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1139\/y91-138","article-title":"Age-dependent alterations in the efficacy of phenylephrine-induced contractions in vascular smooth muscle isolated from corpus cavernosum of impotent men","volume":"69","author":"Christ","year":"1991","journal-title":"Can J Physiol Pharmacol"},{"key":"2024032602340795800_bb0140","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1097\/00004872-200107000-00009","article-title":"Increase generation of superoxide by angiotensin II in smooth muscle cells from resistance arteries of hypertensive patients: Role of phospholipase D-dependent NAD(P)H oxidase-sensitive pathways","volume":"19","author":"Touyz","year":"2001","journal-title":"J Hypertens"},{"key":"2024032602340795800_bb0145","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.vph.2005.08.015","article-title":"Role of oxidative stress in angiotensin-II mediated contraction of human conduit arteries in patients with cardiovascular disease","volume":"43","author":"Puntmann","year":"2005","journal-title":"Vascul Pharmacol"},{"key":"2024032602340795800_bb0150","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ejphar.2008.04.054","article-title":"Superoxide anion mediates angiotensin II-induced potentiation of contractile response to sympathetic stimulation","volume":"589","author":"Lu","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"2024032602340795800_bb0155","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/nau.20219","article-title":"Effect of partial bladder outlet obstruction on nitrotyrosine levels and their correlation with contractile function","volume":"25","author":"Mannikarottu","year":"2006","journal-title":"Neurourol Urodyn"},{"key":"2024032602340795800_bb0160","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0022-5347(01)65369-2","article-title":"Nitric oxide in the penis: Physiology and pathology","volume":"157","author":"Burnett","year":"1997","journal-title":"J Urol"},{"key":"2024032602340795800_bb0165","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.2174\/138161206778343118","article-title":"Phosphodiesterase 5 inhibitors-drug design and differentiation based on selectivity, pharmacokinetic and efficacy profiles","volume":"12","author":"Supuran","year":"2006","journal-title":"Curr Pharm Des"},{"key":"2024032602340795800_bb0170","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/ncpuro0186","article-title":"Drug insight: Oral phosphodiesterase type 5 inhibitors for erectile dysfunction","volume":"2","author":"Briganti","year":"2005","journal-title":"Nat Clin Pract Urol"},{"key":"2024032602340795800_bb0175","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/01.crd.0000233904.77128.49","article-title":"Type 5 phosphodiesterase inhibitors in the treatment of erectile dysfunction and cardiovascular disease","volume":"15","author":"Ravipati","year":"2007","journal-title":"Cardiol Rev"},{"key":"2024032602340795800_bb0180","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1159\/000176035","article-title":"The in vitro and in vivo effects of vardenafil (a PDE-5 inhibitor) on corpus cavernosal smooth muscle relaxation in diabetic rabbits","volume":"82","author":"Lau","year":"2009","journal-title":"Urol Int"},{"key":"2024032602340795800_bb0185","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1111\/j.1743-6109.2011.02416.x","article-title":"Phosphodiesterase type 5 expression in human and rat lower urinary tract tissues and the effect of tadalafil on prostate gland oxygenation in spontaneously hypertensive rats","volume":"8","author":"Morelli","year":"2011","journal-title":"J Sex Med"},{"key":"2024032602340795800_bb0190","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3317\/jraas.2005.021","article-title":"High angiotensin II responsiveness is associated with decrease endothelium-dependent relaxation in human arteries","volume":"6","author":"Voors","year":"2005","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"2024032602340795800_bb0195","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0090-4295(99)00612-3","article-title":"Intravenous alprostadil alfadex (edex\/viridal) is effective and safe in patients with erectile dysfunction after failing sildenafil (Viagra)","volume":"55","author":"Shabsigh","year":"2000","journal-title":"Urology"},{"key":"2024032602340795800_bb0200","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S0022-5347(05)65866-1","article-title":"Long-term efficacy of sildenafil and tachyphylaxis effect","volume":"166","author":"El-Galley","year":"2001","journal-title":"J Urol"},{"key":"2024032602340795800_bb0205","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1111\/j.1743-6109.2007.00567.x","article-title":"Functional and morphological improvement in erectile tissue of hypertensive rats by long-term combined therapy with phosphodiesterase type 5 inhibitor and losartan","volume":"4","author":"Toblli","year":"2007","journal-title":"J Sex Med"}],"container-title":["The Journal of Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609515303477?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609515303477?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/10\/5\/1251\/48192990\/jsm_10_5_1251.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/10\/5\/1251\/48192990\/jsm_10_5_1251.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T02:39:04Z","timestamp":1711420744000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jsm\/article\/10\/5\/1251\/6940188"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,1]]},"references-count":40,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2013,5,1]]},"published-print":{"date-parts":[[2013,5,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1743-6109.2012.02768.x","relation":{},"ISSN":["1743-6109","1743-6095"],"issn-type":[{"value":"1743-6109","type":"electronic"},{"value":"1743-6095","type":"print"}],"subject":[],"published-other":{"date-parts":[[2013,5]]},"published":{"date-parts":[[2013,5,1]]}}}